Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long Term
Condition(s):Rasmussen EncephalitisLast Updated:January 8, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Rasmussen EncephalitisLast Updated:January 8, 2024Recruiting
Condition(s):Optic Neuritis; Transverse Myelitis; Acute Disseminated Encephalomyelitis; Multiple Sclerosis; Neuromyelitis Optica Spectrum Disorder; Anti-NMDAR Encephalitis; Anti-GAD65 Associated Autoimmune Encephalitis; Anti-AMPAR-1/2 Associated Autoimmune Encephalitis; Anti-Lgi-1 Associated Autoimmune Encephalitis; Anti-CASPR-2 Associated Autoimmune Encephalitis; Anti-GABAR-1/2 Associated Autoimmune Encephalitis; Onconeuronal Antibody (Hu, Ri, Yo, Amphiphysin, CRMP-5, Ma-1, Ma-2, SOX-1) Associated Autoimmune Encephalitis; Hashimoto Encephalitis; CNS Vasculitis; CNS Sarcoidosis; CNS Lupus; Rasmussen EncephalitisLast Updated:March 14, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.